FTO and neoplasm: CS1 and CS2 increased the m6A level (Supplementary Fig. 2k), while it decreased cell growth (Supplementary Fig. 2l), tumor growth (Fig. 2k), and tumor weight (Fig. 2l), supporting the anti-tumor effects of these FTO inhibitors in As-T cells.